DoD Melanoma, Survivorship Research Award | HT942525MRPSRA

Opportunity Information: Apply for HT942525MRPSRA

The DoD Melanoma, Survivorship Research Award (Funding Opportunity Number HT942525MRPSRA) is a discretionary grant program run by the Department of the Army through USAMRAA that targets melanoma survivorship, a space described in the announcement as relatively new and underfunded. The central purpose is to fund innovative, high-impact research that is designed to improve the health and well-being of people living after a melanoma diagnosis, with benefits that can also extend to survivors families and caregivers. The opportunity is not centered on basic survival outcomes alone; instead, it emphasizes outcomes that matter during and after treatment, such as quality of life, overall health, day-to-day functioning, and the broader survivorship experience.

A key expectation is that proposed projects are meaningfully grounded in real-world survivorship needs. Research that focuses exclusively on animal models is explicitly considered non-responsive, and proposals that only measure survival without addressing quality of life, health status, or functional outcomes are also considered outside the intent of the award. In practical terms, applicants should frame their study around survivorship challenges and measurable improvements in lived outcomes, rather than limiting aims to disease-free survival or mortality endpoints without connecting them to how survivors actually feel and function.

The program also requires built-in consumer collaboration. Every application must include at least one melanoma consumer collaborator, meaning a melanoma survivor, a family member, and/or a caregiver who brings lived experience to the research team. As an alternative, an application may partner with a melanoma-community supporting organization, as long as that organization is integral to planning, executing, and implementing the research. This is not presented as a symbolic role; the collaborator or organization is expected to actively shape the project so that the research questions, methods, and outputs remain relevant and usable for the survivor community.

Clinical trials are allowed under this funding opportunity, which opens the door to interventional studies aimed at improving survivorship outcomes. While the announcement does not specify the exact budget cap in the provided text, it notes an anticipated number of awards of two, indicating a competitive program with limited funding slots.

Administratively, the opportunity is categorized under Science and Technology and other Research and Development and is associated with CFDA number 12.420. Eligibility is listed as unrestricted, which generally signals that a wide range of applicant organizations may apply (subject to standard federal grant requirements). The original closing date is October 1, 2025, and the opportunity was created on May 14, 2025. Overall, the award is designed for teams proposing survivor-centered melanoma research with clear, practical impact, and with melanoma survivor or caregiver perspectives embedded directly into the work.

• The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Melanoma, Survivorship Research Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on 2025-05-14.
• Applicants must submit their applications by 2025-10-01. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 2 candidate(s).
• Eligible applicants include: Unrestricted.

Apply for HT942525MRPSRA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: